Here's the Best Dividend Stock in Big Pharma


After taking it on the chin to begin the year, Big Pharma stocks have staged a comeback. The iShares U.S. Pharmaceuticals ETF had given up almost 20% near the beginning of 2016 but is now just down just a few percentage points for the year.



from Biotech News